BioMarin Pharmaceutical Inc. is an American biotechnology company headquartered in San Rafael, California. It has offices and facilities in the United States, South America, Asia, and Europe. BioMarin's core business and research are in enzyme replacement therapies. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for BioMarin (United Kingdom), United Kingdom, covering academic research published from 2010 to 2024. Read More.
Open Access Percentage
82%
Total
Publications
106
Total Open
Publications
87
Total
Citations
2.2K
Open Access
Percentage
82%
Total
Publications
106
Total Open
Publications
87
Total
Citations
2.2K
Breakdown
Publisher Open
32%
Both
49%
Other Platform Open
1%
Closed
18%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 48%
41
Hybrid 42%
36
No Guarantees 10%
8
Other Platform Open
Domain 83%
43
Institution 35%
18
Other Internet 13%
7
Public 2%
1
Preprint 0%
0
Other Platform Locations
Name | Platform Type | Publications |
---|---|---|
PubMed Central | Domain | 43 |
DANS - Data Archiving and Networked Services | Institution | 6 |
Unknown Repository | Other Internet | 5 |
University of Buenos Aires - Sociedad | Institution | 4 |
University of Melbourne - Minerva Access | Institution | 3 |
Europe PMC | Domain | 3 |
AECID Library - Americanae | Institution | 3 |
University of Groningen / Centre for Information Technology - University of Groningen research database | Institution | 2 |
RISalud Institutional Health Repository of Andalucía | Institution | 2 |
Le Centre pour la Communication Scientifique Directe - HAL - Diderot | Institution | 2 |